Adjuvant radiotherapy in sinonasal mucosal melanoma: A retrospective analysis

Adjuvant radiotherapy in sinonasal mucosal melanoma: A retrospective analysis KeypointsSinonasal melanomas.Adjuvant radiotherapy.INTRODUCTIONSinonasal mucosal melanoma is a rare malignancy with a reported incidence rate of 0.05 per 100 000 in the United States. In the Netherlands, this disease accounts for 8% of all sinonasal malignancies. The prognosis is poor, with an estimated 5‐year overall survival (OS) of 21.8%‐40.1%. The aggressive behaviour of this tumour results in advanced disease at diagnosis and high rates of local (38%‐46.6%) and distant recurrence (34.6%‐66%).Due to the low incidence of this disease, the development of a standardised treatment protocol and prognostic models has been difficult. Surgical resection with clear margins has been the key mode of treatment with curative intent. Ideally, all unilateral mucosa should be removed, as this malignancy often presents with multifocal lesions that could easily be missed. However, given the complex anatomy of the sinonasal tract with close relation to vital structures, radical resection is often hard to achieve. In case of incomplete resection, post‐operative radiotherapy is advocated. No consensus has been reached regarding the use of adjuvant radiotherapy: while some studies reported better local control and sometimes even better OS, other studies did not find any difference. The same problem applies for prognostic factors for recurrence and survival: the predictors reported http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Otolaryngology Wiley

Adjuvant radiotherapy in sinonasal mucosal melanoma: A retrospective analysis

Loading next page...
 
/lp/wiley/adjuvant-radiotherapy-in-sinonasal-mucosal-melanoma-a-retrospective-ih2TKCMSFg
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 John Wiley & Sons Ltd
ISSN
1749-4478
eISSN
1749-4486
D.O.I.
10.1111/coa.13033
Publisher site
See Article on Publisher Site

Abstract

KeypointsSinonasal melanomas.Adjuvant radiotherapy.INTRODUCTIONSinonasal mucosal melanoma is a rare malignancy with a reported incidence rate of 0.05 per 100 000 in the United States. In the Netherlands, this disease accounts for 8% of all sinonasal malignancies. The prognosis is poor, with an estimated 5‐year overall survival (OS) of 21.8%‐40.1%. The aggressive behaviour of this tumour results in advanced disease at diagnosis and high rates of local (38%‐46.6%) and distant recurrence (34.6%‐66%).Due to the low incidence of this disease, the development of a standardised treatment protocol and prognostic models has been difficult. Surgical resection with clear margins has been the key mode of treatment with curative intent. Ideally, all unilateral mucosa should be removed, as this malignancy often presents with multifocal lesions that could easily be missed. However, given the complex anatomy of the sinonasal tract with close relation to vital structures, radical resection is often hard to achieve. In case of incomplete resection, post‐operative radiotherapy is advocated. No consensus has been reached regarding the use of adjuvant radiotherapy: while some studies reported better local control and sometimes even better OS, other studies did not find any difference. The same problem applies for prognostic factors for recurrence and survival: the predictors reported

Journal

Clinical OtolaryngologyWiley

Published: Jan 1, 2018

Keywords: ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial